home PACKAGING Gerresheimer Manufactures Insulin Pen For Sanofi-Aventis

Gerresheimer Manufactures Insulin Pen For Sanofi-Aventis

Gerresheimer AG has commenced the commercial production of ClikSTAR® insulin pens for sanofi-aventis. Medical plastic systems such as insulin pens will be increasingly important in the Gerresheimer product portfolio in future because they incorporate a dosage and application function in addition to being a pure medication packaging.
The industrialisation of the insulin pen was prepared in Wackersdorf, the Gerresheimer Plastics Division’s technology center. Gerresheimer’s Pfreimd plant (Germany) is the place where the individual components are manufactured and assembled under clean room conditions.

“We are delighted about this sanofi-aventis production project because it involves a complex product that demonstrates our leadership in the medical plastic systems market to the pharma industry,” said Uwe Röhrhoff, Chief Executive Officer of Gerresheimer AG.

The re-usable ClikSTAR® insulin pen has received the Good Design Award.

Insulin pens are drug delivery systems in pen format that enable diabetes sufferers to reliably administer their regular insulin doses in a virtually pain-free procedure. Diabetes treatment is gaining in significance from year to year. According to World Health Organization (WHO) estimates, there will be around 350 million diabetes sufferers in the world by the year 2030.

ClikSTAR is a registered trademark of sanofi-aventis.

About Gerresheimer

Gerresheimer is an internationally leading manufacturer of high-quality specialty products made of glass and plastic for the global pharma and healthcare industry. Our comprehensive portfolio of products extends from pharmaceutical vials to complex drug delivery systems such as syringe systems, insulin pens and inhalers for safe medication dosage and application. Together with our partners, we develop solutions which set standards and have role model status in their respective market sectors.

Our Group realizes revenues of around one billion Euros and has 10,000 employees at 45 locations in Europe, North and South America and Asia. We use first-rate technologies, convincing innovations and targeted investments to systematically consolidate our strong market position.